NIH 'Reinventing' An Expanding SBIR Program

SIDEBAR: For More Information Supporters of the controversial funding category are fighting efforts to keep its budget from growing and trying to increase applications in an attempt to mollify critics. Funded by a growing "tax" on federal R&D funds that will total almost $1.2 billion in fiscal year 1997, Small Business Innovation Research (SBIR) grants are becoming increasingly controversial. Intended to help companies with fewer than 500 employees commercialize new technologies, the progr

Written byRobert Finn
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

SIDEBAR: For More Information

Some scientists are displeased that, as mandated in Congress's 1992 reauthorization of the SBIR program, the portion of NIH's R&D budget designated for SBIR is set to grow from 2 percent in 1996 to 2.5 percent in 1997. Critics charge that funded SBIR grants are of lower quality than funded grants for basic research, and that increasing the money reserved for applied science is inappropriate at a time when money for basic research is so hard to come by.

But the SBIR program has many supporters, and they have warded off efforts to keep its budget from increasing. In addition, supporters have foiled attempts that would have required priority scores earned by funded SBIR grants at NIH to be at least as good as the priority scores earned by funded investigator-initiated new research project (R01) awards. Meanwhile, SBIR boosters at NIH are looking for ways to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA